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Background: Psychological stress can influence the severity of multiple sclerosis (MS),
but little is known about neurobiological factors potentially counteracting these effects.
Objective: To identify gray matter (GM) brain regions related to relaxation after stress
exposure in persons with MS (PwMS).
Methods: 36 PwMS and 21 healthy controls (HCs) reported their feeling of relaxation
during a mild stress task. These markers were related to regional GM volumes, heart
rate, and depressive symptoms.
Results: Relaxation was differentially linked to heart rate in both groups (t = 2.20,
p = 0.017), i.e., both markers were only related in HCs. Relaxation was positively
linked to depressive symptoms across all participants (t = 1.99, p = 0.045) although
this link differed weakly between groups (t = 1.62, p = 0.108). Primarily, the volume
in medial temporal gyrus was negatively linked to relaxation in PwMS (t = −5.55,
pfamily−wise−error (FWE) corrected = 0.018). A group-specific coupling of relaxation and GM
volume was found in ventromedial prefrontal cortex (VMPFC) (t = −4.89, pFWE = 0.039).
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Conclusion: PwMS appear unable to integrate peripheral stress signals into their
perception of relaxation. Together with the group-specific coupling of relaxation and
VMPFC volume, a key area of the brain reward system for valuation of affectively relevant
stimuli, this finding suggests a clinically relevant misinterpretation of stress-related
affective stimuli in MS.
Keywords: multiple sclerosis, autoimmunity, neuroinflammation, gray matter, ventromedial prefrontal cortex
(vmPFC), psychological relaxation, psychophysiological stress responses, brain reward system
INTRODUCTION
Multiple sclerosis (MS) is an inflammatory disease of the
central nervous system of presumed autoimmune origin.
It manifests most frequently in young female adults and
leads to demyelination, neurodegeneration, and axonal
damage (1, 2).
Beyond key neurological symptoms, persons with MS
(PwMS) are characterized by stress-related syndromes such
as depression and anxiety which strongly affect social and
work-related factors (3). Adult PwMS score higher on
questionnaires assessing childhood traumatization than
controls (4), and the occurrence of stressful life-events is
coupled to subsequent exacerbation of neurologic symptoms
(5). Neuroendocrine studies identified altered functioning
of biological stress systems in PwMS [e.g., hypercortisolism
for the hypothalamo-pituitary-adrenal axis (HPA); (6)]
and reduced levels of norepinephrine in peripheral blood
lymphocytes for the sympathetic nervous system (7) and
altered immuno-modulatory effects of these systems [e.g.,
reduced corticoid-induced immunosuppression; (8)]. Structural
neuroimaging studies showed that HPA hyperactivity is
positively linked to atrophy of hippocampal subregions (9) and
ventricular size (10) in PwMS. Finally, using a mild cognitive
functional MRI (fMRI) stress task, we showed that blunted
stress responses in insular cortex are linked to stronger clinical
disability in PwMS (11). Together, these findings suggest an
important role of stress for MS and thus advocate for a more
thorough understanding of factors potentially counteracting
its effects.
The ability to relax during stress exposition or therapeutic
relaxation techniques might be such factors. First, the ability to
relax is an important aspect of resilience, a psychological stress
adaption mechanism (12) that is accompanied by higher quality
of life (QoL) and lower anxiety and depression in PwMS (13).
Second, therapeutic relaxation induced by autogenic training
improves health-related QoL in PwMS (14) and, within a larger
stress management program, contributed to a reduction of the
incidence of novel lesions in a randomized controlled trial (15).
Despite these findings underlining the importance of
relaxation for counterbalancing stress effects in PwMS, however,
nothing is currently known about neurobiological factors
underlying relaxation in PwMS. For this reason, and given
the previously shown link between stress-system hyperactivity
and regional gray matter (GM) atrophy in PwMS (9), we
used a mild cognitive stress task comprising mental arithmetic
and performance feedback to measure the level of perceived
relaxation during different levels of stress exposition in 36
PwMS and 21 healthy controls (HCs). Perceived stress was
additionally measured to evaluate the utility of the task to induce
a stress response and to clarify the relation of task-induced
relaxation and stress. Perceived relaxation was then related to
the participants’ regional GM volumes, task-induced heart rate
variations, and degree of depressive symptoms to provide insights
into factors underlying relaxation inMS. Driven by findings of an
“impaired emotional reactivity” or impaired ability to detect and
process emotional threat cues in PwMS and HCs, respectively
(16), we tested two main hypotheses, i.e., whether relaxation is
differentially related to (1) the regional volume of brain areas
involved in affective processes and (2) to stress-related heart-rate
accelerations in PwMS vs. HCs.
METHODS
Participants
Seventy individuals (43 PwMS and 27 HCs) were screened for
participation in this study. PwMS were recruited in cooperation
with the Charité neuroimmunology outpatient clinic whereas
HCs were enrolled by advertisements. To be included, patients
had (1) to be diagnosed with relapsing-remitting (RRMS) or
secondary progressive MS (SPMS) according to the McDonald
Criteria of 2010 (17), (2) be without disease-modifying treatment
or have a stable treatment for at least 6 months, (3) be at
least 18 years old, and (4) be able to participate in the stress
paradigm without physical or mental restriction. Exclusion
criteria were acute MS relapses and unstable MS courses, other
neurological disorders, an existing diagnosis of a psychiatric
disorder, and MRI contraindications. If applicable, inclusion
and exclusion criteria were identical for HCs. After applying
these criteria, 57 participants were included [35 females; 36MS
patients (27 RRMS, 9 SPMS)]. Written informed consent
was obtained from participants according to the Declaration
of Helsinki (18). The study was approved by the research
ethics committee of the Charité—Universitätsmedizin Berlin
(EA1/182/10, amendment V).
Rating data, structural MRI, and data on the extent of
depressive symptoms were available for all 57 participants, pulse
data for a subset of 46 participants. Structural MRI data were
also evaluated for different purposes in (11, 19, 20). Furthermore,
pulse data, and stress but not relaxation ratings were also
evaluated in (11).
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Clinical Assessment
One experienced neurologist examined all MS patients by
conducting the Expanded Disability Status scale (EDSS) (21) to
assess clinical disability. PwMS and HCs completed the Beck
Depression Inventory II (22). For further parameters, please see
(19, 20).
Experimental Task, Psychophysiological
Stress, and Relaxation Measures
The stress paradigm comprised seven stages and had a total
duration of 44min. In the first stage (“Rating I”), participants
rated their current level of feeling relaxed, stressed, anxious, and
frustrated on a 9-level Likert scale (ranging from “not at all”
to “very strong”). The selection of a given intensity for each
psychological marker was performed with an MRI-compatible
response button box. In stage 2, resting fMRI [for an analysis
of fMRI data, see (11)] and pulse data were measured. In
stage 3 (“Rating II”), which took place immediately after fMRI,
the participants again provided self-report data for the four
psychological measures. In stage 4, the mental arithmetic stress
task was conducted while participants were scanned with fMRI
and pulse data were assessed (“Stress task”). The task was derived
from the Trier Social Stress Test (23) and had a total duration
of 12min. In the paradigm, the participants had to perform
a series of subtraction tasks (i.e., “operand X minus operand
Y”) as fast as possible. The two operands were depicted in the
middle of a computer screen inside the scanner. To solve a task,
the participants had to select the single correct result from one
of four numbers depicted on the bottom of the screen with
the button box. Across the first 10 correct trials or maximally
during the trials of the first 4min of the task (i.e., during
the “evaluation stage”), a given participant’s performance level
(i.e., the average time necessary to find the correct solution)
was evaluated to provide feedback in the remaining period of
the 12min (i.e., during the “performance stage”). Specifically,
depending on the difference between the time necessary to find
a correct solution in trials of the performance stage and the
participant’s average performance in the evaluation stage, each
trial’s performance was evaluated in terms of school grades
ranging from “1—sehr gut” (very good) to “5—ungenügend”
(insufficient). Moreover, the time provided to solve each task
was adopted based on the participant’s performance in the
performance stage: If the preceding trial was correctly solved,
the time provided was reduced by 10% in the following trial.
Contrarily, it was prolonged by 10% if the answer was false.
This temporal adaptationmechanismwas employed to guarantee
that all participants constantly performed at their maximal
personal ability level. In the fifth stage, the participants provided
self-report data with regard to the four psychological scales
immediately after fMRI scanning (“Rating III”). In stage 6, a
post-stress resting fMRI and pulse measurement was conducted.
Finally, the stress paradigm ended after the participants provided
rating data for the four scales for a fourth time (“Rating IV”) in
the seventh stage.
Given that stress and thus potentially relaxation responses
differ in terms of immediate and delayed or sustained responses
(11, 24), we computed the differences between relaxation
reported in the post-stress (“Rating III”) minus in the pre-stress
stage (“Rating II”) as immediate and relaxation reported in the
seventh stage (“Rating IV”) minus ratings obtained in the pre-
stress stage (“Rating II”) as delayed relaxation measure. The
corresponding markers were also computed for perceived stress.
Differences in the average heart rate during the last 8min of
(see next section) fourth minus the second stage were computed
as immediate peripheral stress response markers, differences
between stages 6 and 2 as markers of delayed peripheral
stress responses. Finally, we computed the task load for each
participant as the average duration of the inter-trial interval
during the final 8min of the stress task. We focused on the final
8min for heart rate and performance computation to ensure
equal feedback settings across participants. Figure 1 illustrates
the paradigm.
Heart Rate Measurement
Pulse data were assessed during functional imaging with
a standard pulse oximeter (included in the Physiological
Monitoring Unit (PMU) of the MR scanner; Magnetom Trio,
Siemens, Erlangen, Germany) which measures variations in
infrared light transmission (50Hz sampling frequency). To avoid
transmitter dislocation potentially caused by button presses
during the task, the pulse oximeter was placed on the participants’
toes. The quality of pulse signals assessed with this measurement
approach has been proven to be comparable with that of signals
assessed at participants’ fingers (25). We filtered the heartbeat
signal for denoising and thus excluded (1) heartbeats inducing
an acceleration to 133% or higher or a deceleration to 75% or
below and (2) signals within the baseline oximeter raw signal (i.e.,
raw signal values below 2000). To ensure equal feedback settings
across participants (see task description), we only evaluated heart
rate signals measured during the final 8min of the stress task.
MRI Sequences
Structural brain images were measured using a 3-T whole-body
tomograph (Magnetom Trio; Siemens) with a standard head
coil (12 channels). Specifically, anatomical T1-weighted (T1w)
images were measured with a 3D-magnetization prepared rapid
gradient echo MP-RAGE sequence using these parameters: 176
slices; slice thickness 1.3mm; in-plane voxel resolution 1.5 · 1.5
mm2; TR = 1,720ms; TE = 2.34ms; FA = 9◦; FOV = 192 ·
192 mm2; matrix size = 128 × 128; duration 1min and 43 s.
Moreover, sagittal T2-weighted (T2w) images were acquired to
facilitate manual lesion mapping with these parameters: 176
slices; 1-mm isotropic voxels; TR = 5,000ms; TE = 502ms;
FA= 120◦; FOV= 256 · 256 mm2; matrix size= 256 · 256; 5min
and 52 s duration.
MRI Preprocessing
Preprocessing of anatomical MRI images comprised four larger
steps, i.e., (1) a manual lesion mapping, (2) the determination of
tissue probability voxel maps, (3) determination of a gray matter
group mask, and (4) a determination of the intracranial volume.
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FIGURE 1 | Stress paradigm. Please note that the paradigm initially also included a salivary cortisol measurement during all four rating periods. Because we do not
refer to these data in this study, we would like to point the reader to (11) from which also parts of the figure were taken.
(i) Lesion Mapping
To determine participant-specific lesion masks, an expert rater
from the group of Friedemann Paul performed a manual
lesion mapping procedure based on high-resolution T2w-images
with the OsiriX software toolbox (OsiriX Foundation, Geneva,
Switzerland). The lesion masks were exactly the same as the ones
used in (11).
(ii) Determination of Tissue Probability Voxel Maps
To compute voxel maps assessing the probability with which
each voxel in the brain belongs to GM, white matter (WM),
or cerebrospinal fluid (CSF), we first used SPM12 to co-
register the T2w images and the lesion masks derived from
the T2w images to the T1w anatomical images. In the next
step, we spatially registered/normalized the T1w anatomical
image and the co-registered lesion mask of each patient to the
anatomical standard space defined by the Montreal Neurological
Institute (MNI) (26) brain template. For this step, we used
the combined spatial normalization and segmentation algorithm
included in SPM12. The algorithm simultaneously computes
the spatial registration/transformation as well as voxel-wise
tissue probability maps for GM, WM, and CSF in the original
subject-specific and the anatomical standard space. In particular,
the algorithm determines modulated tissue probability maps
in the anatomical standard space that consider/control for
the impact of spatial deformations applied during the spatial
normalization which might vary between PwMS and HCs due to
MS-induced atrophy. In addition, the algorithm also computes
non-modulated tissue probability maps which were however not
used in the present study. Coordinates located in lesioned tissue
as reflected by the co-registered lesionmasks of a subject were not
used for this registration procedure. The voxel size of modulated
tissue probability images determined in the anatomical standard
space was 3 · 3 · 3 mm3. The (all) tissue probability maps
computed were the same as the ones used in (11). The tissue
probability voxel images reflecting the modulated probability
with which voxels belong to GM were entered in the MRI
group analyses.
(iii) Determination of a GM Group Mask
To constrain all MRI group analyses to brain areas located in
GM, we then determined a group mask for this tissue across all
participants in three steps. In particular, we computed the voxel-
wise average tissue probability (based on modulated and non-
smoothed tissue probability maps determined in the anatomical
standard space; see previous section) for GM, WM, and CSF
across all 57 participants in the first step. Afterwards, a voxel
coordinate was assigned to that tissue for which the maximal
averaged tissue probability was determined. Voxel coordinates
for which GM had the maximal average tissue probability were
included in the GM group mask. In the second step, we removed
voxel coordinates from the mask generated in step 1 that were
located in lesioned tissue (and the six direct neighbor voxel
coordinates having a Euclidean distance of exactly one voxel
to control for potential partial voluming effects) in at least one
patient as determined by spatially normalized lesion map of
a patient to ensure that lesions did not affect our subsequent
MRI group analyses. Finally, in the third step, we removed
coordinates located outside the mask of the intracranial volume
provided by SPM12. Following these three steps, the coordinates
included in our GM group mask spanned 46% of the total
intracranial volume.
(iv) Determination of the Intracranial Volume
The participant-specific intracranial volume (ICV) was
computed as the number of voxels with non-zero tissue
probability determined across all tissue types and based on tissue
probability maps in the original, subject-specific image space
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and the respective co-registered T2w lesion masks. The ICV
was used as covariate of no interest in our MRI group analyses
(see Supplementary Material).
Statistical Analyses of Psychophysiological
Relaxation and Stress Measures
This set of analyses comprised four individual analyses. In
psychophysiological analysis 1, we evaluated basic effects of task
exposure on psychophysiological relaxation and stress response
parameters. Specifically, we tested basic effects of task exposure
(i.e., task stage) on perceived relaxation, perceived stress, and
heart rate variations across all participants independent of group
membership (main effect of task stage), whether these measures
differed between groups independent of task stage (main effect
of group), and finally whether the impact of individual task
stages differed between groups (interaction effect of task stage
and group). This was separately done for immediate and delayed
relaxation, stress, and heart rate in six individual factorial linear-
mixed effects (LMEs) analyses [cf. (27)]. Each of these six analyses
was done using the FITLMEMATRIX algorithm implemented
in Matlab 2014a (MathWorks, Natick, Massachusetts, USA). A
regressor coding for the task stage served as first fixed covariate
of interest (CI). In particular, this regressors coded zeros for
stage 3 and ones for stage 5 for analyses of immediate stress or
relaxation and zeros for stage 3 and ones for stage 7 for analyses
of delayed stress or relaxation. Similarly, it coded zeros for stage
2 (2) and ones for stage 4 (6) for analyses of immediate (delayed)
heart rate variations. The second fixed CI was a regressor for
group (0 HC, 1 PwMS), and the third an interaction regressor
computed as the product of task stage and group. Regressors
for sex, age, and task load (plus constant) were entered as fixed
covariates of no interest (CNI), and a constant as random CNI.
Ratings obtained in stages 3 and 5 served as criteria in analyses
of immediate effects, those obtained during stages 3 and 7 in
analyses of delayed effects. Averaged heart rate signals measured
during stages 2 and 4 served as criteria for the analysis of
immediate heart rate variations, average pulse signals sampled in
stages 2 and 6 for delayed pulse variations. To compute measures
of inferential statistics, we used permutations testing [5,000
permutations (28)].
In psychophysiological analysis 2, we investigated the
association between relaxation and stress as well as between
immediate and delayed relaxation. Specifically, we used robust
regression (i.e., the ROBUSTFIT Matlab algorithm) to predict
the two relaxation difference markers based on the two
corresponding stress differencemarkers across all 57 participants.
Sex, age, task load, and a constant served as CNI. In addition,
we predicted our delayed relaxation marker based on the marker
assessing immediate relaxation.
To test the effects of relaxation, group, and their interaction
on peripheral stress responses, we conducted one factorial robust
regression analysis to model immediate and one to model
delayed heart rate variations in psychophysiological analysis 3.
Specifically, regressors for immediate (delayed) relaxation, group,
and their interaction (calculated as the product of the given
relaxation difference marker and group) served as CI, sex, age,
and task load (plus constant) as CNI. Immediate or delayed heart
rate variations served as criteria. Permutation testing was used
for inference (5,000 permutations).
Finally, in psychophysiological analysis 4, we analyzed the
clinical relevance of our relaxation parameters by relating them to
depressive symptoms (i.e., BDI-II). These analyses were identical
to the ones described for step 3, except for the fact that BDI-
II scores and not averaged heart rate served as criterion in all
analyses. For all analyses of psychological stress and relaxation,
we report the t-statistic for the CI and the false-positive rate for
this t-statistic as determined by permutation testing (α = 0.05).
Statistical Analysis of Structural MRI Data
In voxel-based morphometry (VBM) analyses performed with
SnPM13 (https://warwick.ac.uk/fac/sci/statistics/staff/academic-
research/nichols/software/snpm), we tested (i) associations of
perceived relaxation and regional GM volume in PwMS (i.e.,
the main effect of relaxation on GM volume in PwMS), and
(ii) whether the association between perceived relaxation and
regional GM volume differs between PwMS and HCs (i.e.,
the interaction effect of relaxation and group on regional GM
volume). SnPM13 is a toolbox for SPM12 (Wellcome Trust
Center for Neuroimaging, Institute of Neurology, UCL, London,
UK—http://www.fil.ion.ucl.ac.uk/spm) that uses permutation
testing for inference and the maximum statistic approach to
control for multiple comparisons. Each of these analyses was
once conducted for immediate and once for delayed relaxation.
Sex, age, task load, and ICV (plus constant) served as CNI
in (i) and (ii), main effect regressors coding for the given
relaxation marker and group additionally in (ii). All analyses
were constrained to voxel coordinates located in a GM group
mask. In each analysis, 5,000 permutations were performed to
assess significance. We report coordinates for voxels showing
a significant positive or negative effect according to a multiple
comparison or family-wise error (FWE) corrected threshold
(αFWE = 0.05) in the anatomical standard space defined by the
MNI (26). Furthermore, we report the t-statistic for this voxel, the
FWE-corrected p-value, and the spatial extent/volume of voxels
reaching significance. Please note that we report the results of
four additional VBM analyses in the Supplementary Material.
Specifically, (1) the first one evaluated differences in the regional
GM volume between PwMS and HCs, and (2) another one
that repeated the two main VBM analyses reported earlier
which however were anatomically constrained to those areas
identified in the first supplementary analysis. Moreover, (3)
a third one investigated associations between relaxation and
regional GM volume in HCs only, and (4) the fourth tested the
link between psychological relaxation measures and regional GM
volume in PwMS but additionally modeled the putative impact




Themedian age in PwMSwas 49.7 years (range 21.9–61) and 51.4
years (range 25.1–64.0) in HCs (t = −0.59; p = 0.547). Twenty-
two of 36 PwMS and 13 of 21 HCs were female (χ2 = 0.00,
p > 0.999). Also, 58.3% of the patients and 76.2% of HCs had
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a high school diploma (χ2 = 1.86, p = 0.250). Although none of
the PwMS had a clinical diagnosis of a depressive disorder at the
time of investigation, depressive symptoms (i.e., BDI-II corrected
for effects of sex and age) were higher in PwMS thanHCs (PwMS:
median: 5.5, range: 0–22; HCs: median: 1, range: 0–10; t = 2.98,
p= 0.005).
Patients showed a median EDSS of 3.5 (range 1.5–6). Fourteen
patients were treated with subcutaneous disease-modifying
medication (7 with β-interferons, 7 with glatiramer acetate)
and 16 with oral medication (8 with dimethylfumarate, 6 with
fingolimod, 2 with teriflunomide), while 6 patients were not on
any pharmacological treatment. The median disease duration
was 6.4 (range 0.3–21.2) years, median number of relapses since
diagnosis was 5 (range 1–21), and the median number of days
since the last relapse was 654 days (range 22–3,550).
Statistical Analysis of Psychophysiological
Relaxation and Stress Measures
Analyses of basic task effects (psychophysiological analysis 1)
showed that the transition from the pre-stress stage (stage 3 for
stress and relaxation, stage 2 for heart rate) to the stress task
(heart rate: stage 4) or the first post-stress stage, respectively
(stage 5 for stress and relaxation) induced a significant variation
in all three psychophysiological parameters independent of group
membership (main effect of task stage for immediate responses).
For delayed effects, no main effect of task stage was found.
Groups did not differ in any of the three measures independent
of task stage—neither in terms of immediate nor in terms of
delayed response (i.e., no main effects of group were found).
Finally, task stages also did not exert a different impact on
the three measures in the two different groups—neither for
immediate nor for delayed responses (i.e., no interaction effects
task stage × group were found). These findings are summarized
in Figure 2A.
Psychophysiological analysis 2 investigating associations
between relaxation and stress as well as between immediate and
delayed relaxation showed that (1) immediate relaxation was
negatively linked to immediate stress (t = −2.23, p = 0.032).
In this analysis, 8% of the variance in the immediate relaxation
marker (corrected for CNI) were explained by the variation in the
immediate stress marker. Consistently, (2) a comparable relation
was obtained for the corresponding markers assessing delayed
effects (t = −2.17, p = 0.035; 4% explained variance). Finally,
the association between immediate and sustained relaxation
was strong (t = 5.65, p < 2 · 10−4; 47% explained variance).
Findings regarding psychophysiological analysis 2 are shown
in Figure 2B.
In psychophysiological analysis 3, which evaluated effects
of relaxation, group, and their interaction on peripheral stress
responses, we found that an (immediate) increase in heart rate
from stage 2 (Rest I) to 4 (Stress task) induced a significantly
stronger reduction in perceived relaxation in HCs than PwMS.
Patients’ perception of relaxation apparently did not reflect task-
induced immediate variations in heart rate (interaction effect
immediate relaxation × group on immediate heart variations;
t = 2.20, p = 0.017; left graph in Figure 3). No interaction
effect for delayed responses was found. Groups did not differ
in terms of immediate or delayed heart rate responses—neither
for immediate nor for delayed responses (i.e., no main effect of
group was found) and no overall association of relaxation and
heart rate variations was found—neither for immediate nor for
delayed responses (i.e., no main effect of relaxation was found).
Table 1A shows the statistics for all reported effects evaluated in
psychophysiological analysis 3.
Finally, in psychophysiological analysis 4, which evaluated
effects of relaxation, group, and their interaction on the extent
of depressive symptoms (i.e., BDI-II), we found an association
of immediate relaxation and BDI-II scores across all participants
(main effect of immediate relaxation; t = 1.99, p = 0.045; right
graph in Figure 3). Table 1B shows the statistics for all effects
evaluated in psychophysiological analysis 4.
Statistical Analysis of Structural MRI Data
Associations of Perceived Relaxation and Regional
GM Volume in PwMS
In the first VBM analysis testing main effects of relaxation
on regional GM volume in PwMS, we found a negative
association between immediate relaxation in fusiform gyrus
(FG) and middle temporal gyrus (MTG; in other words,
higher GM volume in these areas was linked to lower
immediate relaxation). For delayed relaxation and GM, a
negative link was found for volume in the MTG and enthorinal
cortex (ENTH).
Differential Association of Perceived Relaxation and
Regional GM Volume in PwMS and HCs
Finally, in the VBM analysis testing interaction effects between
relaxation and group on regional GM volume, a negative
interaction was found for delayed relaxation and GM volume in
ventromedial prefrontal cortex (VMPFC). Please see Table 2 and
Figure 4 for further details.
DISCUSSION
In this study, we investigated psychophysiological and brain
morphometric parameters of relaxation in 36 PwMS and related
them to those observed in 21 HCs. The main results revealed
by our analyses were (1) a different link between relaxation and
stress-induced heart rate accelerations in PwMS than HCs, (2)
an important role of temporal areas for relaxation in PwMS,
and finally (3) a different link between relaxation and regional
volume of VMPFC in PwMS than HCs. The VMPFC is a key area
of the brain reward system heavily involved in the valuation of
affectively relevant stimuli [e.g., (29–31)].
Several analyses were conducted in the study. To evaluate
the basic characteristics of our task-based assessment technique
and measures, a first analysis of psychophysiological data tested
the ability of the task to induce perceived stress and variations
in heart rate as well as whether the relaxation parameters
were sensitive to the task. Not surprisingly, given the results
of a corresponding analysis in (11), the task increased the
level of perceived immediate stress and triggered immediate
heart rate accelerations across all participants independent of
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FIGURE 2 | Psychophysiological stress and relaxation responses. Boxplots in (A) illustrate the impact of task stage, group, and their interaction on immediate and
delayed stress, relaxation, and heart rate. In each boxplot, the dotted line corresponds to the median of a given measure, and the upper (lower) edge of a box to the
third (first) quartile of a given measure. Whiskers highlight the most extreme points not considered as outliers. The outlier range was considered to start at the first
[third] quartile minus [plus] 1.5 times the interquartile range. As indicated by these graphs, the proportion of outliers was very small. The statistics reported were
computed with LME regression (see text for details). Scatterplots in (B) show the association between immediate and delayed relaxation, immediate stress and
relaxation, and delayed stress and relaxation.
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FIGURE 3 | Associations between immediate relaxation and task-induced heart-rate variations or depressive symptoms, respectively. §Please again note that we do
not provide the group differences in depressive symptoms computed in the factorial analyses at this place for the same reason as reported in Table 1.
TABLE 1 | (A) Relation of relaxation and heart rate as well as (B) relation of
relaxation and depressive symptoms.












































§Please note that we do not report the group differences in depressive symptoms
computed in the factorial analyses at this place because this would necessitate reporting
two varying differences (due to the varying covariation among predictors)—one computed
for the model with immediate and one for the model with delayed relaxation as covariate
of interest. Instead, we consider the difference reported in the Results section Sample
characteristics (including sex and age as covariates of no interest) as reference (i.e.,
t = 2.98, p = 0.005).
group membership. Exceeding what has been shown in the
latter study, the analysis of perceived relaxation data showed
that the task induced a significant reduction in feeling relaxed
from Rating II to III. Interestingly, no group differences
TABLE 2 | Brain regions and relaxation.
Associations of perceived relaxation and regional GM volume in PwMS
MNI region CS x y z t pFWE
Immediate relaxation
FG 27 42 −34 −19 −5.33 0.033
MTG 27 54 −46 −7 −5.17 0.047
Delayed relaxation
MTG 54 54 −49 −7 −5.55 0.018
ENTH 27 24 2 −37 −5.19 0.042
MTG 27 57 −28 −19 −5.13 0.047
Differential association of perceived relaxation and regional GM volume
in PwMS and HCs
Delayed relaxation × group
VMPFC 108 0 41 −25 −4.89 0.039
MNI, Montreal Neurological Institute; CS, cluster size (mm3 ); x, y, z, coordinates in
MNI space; t, t statistic; pFWE , family-wise-error corrected (αFWE = 0.05) probability for
observing the given t value by chance on the voxel level; FG, fusiform gyrus; MTG, middle
temporal gyrus; ENTH, enthorinal cortex; VMPFC, ventromedial prefrontal cortex.
were found in any of the three tested variables—neither for
immediate nor for delayed effects. Thus, the overall ability to
perceive relaxation and stress appears to be unaffected by MS.
Furthermore, none of the measures had a task stage–specific
effect that differed between groups/no interaction effects were
found. Behavioral analyses relating immediate and delayed stress
responses to immediate and delayed relaxation responses showed
a negative link in both cases. Importantly, however, although
these negative associations were significant, they were not very
strong (i.e., 8% mutually explained variation in the markers
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FIGURE 4 | Brain regions and relaxation. Highlighted coordinates in brain slices in the upper panel depict voxels whose GM volume was negatively related to delayed
relaxation in PwMS (i.e., showing a negative main effect of delayed relaxation on regional volume in PwMS). The scatterplot on the right side of the upper panel
depicts this differential association for the peak voxel coordinate found in the respective analysis, i.e., a coordinate in MTG (MNI: 54, −49, −7). Highlighted
coordinates in brain slices in the lower panel depict voxels whose GM volume was differentially related to delayed relaxation in both groups (i.e., voxels showing an
interaction effect between delayed relaxation and group on regional volume). The scatterplot on the right side of the lower panel depicts this differential association for
the peak voxel coordinate found in the respective analysis, i.e., a coordinate in VMPFC (MNI: 0, 41, −25). Please note that we depict voxels significant according to an
uncorrected threshold of α < 10−3 for visualization purposes in this figure.
for immediate effects and 4% for markers of delayed effects).
Consequently, one might assume that the relaxation and stress
parameters do not reflect the same phenomenon and are thus
not redundant. Finally, an analysis relating the immediate to
delayed relaxation markers revealed a strong positive relation
between the two (47% explained variance). Thus, immediate
and delayed relaxation responses appear to emerge from one
comparably homogenous latent factor “relaxation after exposure
to stress.”
Analyses evaluating associations between relaxation,
group, and heart rate revealed that the association between
immediate relaxation and immediate heart rate accelerations
was significantly more negative in HCs than in PwMS.
Specifically, in patients, the link between heart rate accelerations
appeared to be very weak, whereas HCs’ relaxation ratings
appeared to decline together with immediate heart rate
accelerations. This finding fits well to results of a study by
(16), who investigated decision-making capabilities in PwMS.
Specifically, using a gambling task requiring (1) to learn which
two of four decks of cards were coupled to a loss across a
series of choices and (2) the acquisition and perception of
emotional arousal (heightened skin conductance responses;
SCRs) before potentially disadvantageous choices (16) found
that arousal and performance were lower in PwMS than HCs.
Consequently, they concluded that PwMS are characterized
by an “impaired emotional reactivity’’-–or in other words
a reduced ability to perceive interoceptive cues signaling
threat. This is strongly related to our previously mentioned
finding: Contrary to HCs, PwMS were not able to rest their
relaxation assessment on peripheral signals indicating socially
evaluative threat.
When the clinical relevance of our relaxation markers was
explored by relating them to participants’ weak to moderate
depressive symptoms, a positive link to immediate relaxation
was found across all 57 participants (i.e., higher ratings of
relaxation were associated with higher BDI-II scores; t = 1.99;
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p = 0.045, see Table 1B). Despite not significant on a false
positive rate of α = 0.05, the results obtained in the same
analysis for the interaction effect (immediate relaxation ×
group: t = 1.62, p = 0.108; Table 1B and Figure 3) might
suggest that the positive main effect is primarily driven by
PwMS. This positive association might become understandable
when additionally considering the findings obtained in our
second main VBM analysis. Therefore, we would like to point
the reader to the Discussion of this second VBM analysis in
this regard.
To investigate brain volumetric correlates of relaxation, we
conducted two main and four supplementary VBM analysis.
In the first main analysis, associations between relaxation on
regional GM volume in PwMS only were tested. Results of
this analysis suggest an important role of temporal areas for
relaxation as regional volumes in FG and MTG (MTG and
ENTH) were negatively linked to immediate (delayed) relaxation.
Interestingly, given the close link between relaxation and
resilience, these temporal areas are involved in threat processing
(32) and among key areas found in PTSD studies. In particular
(33) found a volume reduction in PTSD patients compared with
HCs in MTG and FG. Moreover (34) revealed a negative link
between the frequency of re-experiencing symptoms and GM
volume in MTG in PTSD and (35) a positive association between
resilience assessed with a questionnaire and GM thickness in FG
of HCs. Finally, persons confronted with traumatizing events
who did not develop a PTSD in response to trauma exposure
had a higher cortical thickness in FG than persons developing
PTSD (36). Consequently, the regions identified as being related
to relaxation in PwMS match those found in related studies on
resilience and PTSD.
However, despite the fact that the regions found in our
study strongly overlap with regions found in PTSD studies,
the negative direction of associations between relaxation and
temporal volumes appears as counter-intuitive as the positive
link between task-based relaxation and depressive symptoms
reported (primarily for PwMS) earlier. This becomes evident
when considering that the volume of temporal areas was
positively linked to resilience in HCs (35) or that the frequency of
re-experiencing PTSD symptoms and GM volume in MTG was
negatively associated (34). Consequently, one might ask whether
the neural mechanism underlying the relaxation evaluation is
biased in PwMS.
The results of the second main VBM analysis, which revealed
a differential coupling between relaxation and regional GM
volume in PwMS and HCs for VMPFC coordinates together
with the finding of a differential coupling of relaxation and
heart rate in PwMS and HCs, argue that this is presumably the
case. This becomes clear when the functional roles of VMPFC
are considered. Specifically, the VMPFC is a key area of the
brain reward system that links the value of stimuli [positive for
rewarding ones such as food [e.g., (30)], negative for punishing
ones such as electric shocks [e.g., (37)] to hedonic experience
(31). Within this framework, activity of this area can be
considered as a neuronal safety/threat signal as this area responds
stronger to reward (-predictive) than to punishment (-predictive)
stimuli in healthy persons. Moreover, because VMPFC is also a
regulator of sympathetic nervous functions (38), it also triggers
a peripheral safety/threat signal of opposing direction as the
neural one in healthy individuals (e.g., an increase in SCRs
in response to punishment-predictive stimuli). Moreover, both
behaviors change under threat in the healthy: VMPFC activity
decreases and SCRs increase (37).
These responses, however, are altered in PwMS and this
alteration has behavioral consequences: In line with our earlier
assumption of a biased processing of affectively relevant, reward-
related stimuli in MS, SCRs to punishment-predictive stimuli
were weaker in PwMS than in HCs in the gambling task
used by (16) and their task performance (relying on the
perception of these punishment-predictive responses) was worse.
Simultaneously, the worse performance of PwMS in this task is
related to VMPFC activity as our recent fMRI study employing
the same task as (16) in the participants that were also analyzed
in the present study showed that VMPFC activity is positively
associated with task performance across PwMS and HCs despite
this difference in performance (20).
Given the existing work on stress-related processes
contributing to GM alterations in MS, conceiving a mechanism
underlying this altered link between relaxation and regional
VMPFC volume in MS is a challenging task. Speculatively,
a candidate mechanism might be inferred from (1) chronic
glucocorticoid system/HPA hyperactivity and thus insensitivity
repeatedly observed (in certain tissues) in PwMS [e.g., (6)]
and (2) the fact that glucocorticoid insensitivity of the rat
VMPFC alters stress-processing or more specifically induces
a hypersensitivity to stress indicated by, e.g., depression-like
behavior (39). Consequently, based on the existing literature,
one might speculate that glucocorticoid insensitivity of the
VMPFC due to HPA hyperactivity in MS is accompanied by
a systematic misinterpretation of stress signals which might
in turn be related to the extent of depressive symptoms and
thus clinically relevant. Moreover, given the previously shown
link between HPA hyperactivity and hippocampal atrophy in
more depressed PwMS (9) and the overall role of hippocampal
and neighboring enthorinal areas in mood regulation (40),
one might further speculate that this or a related mechanism
might also drive the negative link between relaxation and
regional temporal GM volume in PwMS. Please note that this
explanation might hold despite the fact that PwMS were not
characterized by less VMPFC or temporal volume (at these
specific coordinates) than HCs as the MRI technique applied
in the present study (i.e., evaluating MP-RAGE images with
VBM) might miss variations in the tissue microstructure [such
as a reduced glucocorticoid receptor density underlying stress
hypersensitivity in (39); cf. (41)].
In addition to the two VBM analyses presented in the
main text, four supplementary VBM analyses were conducted.
The first tested volume differences between PwMS and HCs
and identified loss of GM volume in PwMS in thalamic
areas (which is consistent with findings on MS-induced
atrophy) and, to a lesser degree, in MTG (42, 43). However,
these areas characterized by GM volume loss in PwMS
turned out to be of limited importance for relaxation-
related tissue alterations in PwMS because a repetition of the
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two VBM analyses presented in the main text constrained
to the coordinates found in the first supplementary VBM
analysis in supplementary VBM analysis 2 did not reveal
any significant associations. When additionally considering
that non-atrophy affected areas did show an association with
relaxation in PwMS, this finding might underline the possibility
of subtle, functionally relevant, MS-driven tissue alterations
which are within the range of tissue variations observed in
the healthy.
To facilitate a comparison between associations of relaxation
and regional GM volume in PwMS with those found in HCs, we
investigated associations of relaxation and regional GM volume
in HCs only in supplementary VBM analysis 3. Using a sensitive
significance threshold (αuncorrected = 0.001), this analysis revealed
several coordinates with positive and negative associations
primarily located in temporal, visual, and parietal regions.
None of these areas reached significance according to the more
conservative threshold applied in the corresponding PwMSVBM
analysis (i.e., αFWE = 0.05). However (within this more liberal
testing framework), supplementary VBM analysis 3 obtained
results compatible with those reported in the resilience and PTSD
literature mentioned earlier (34, 35), i.e., that regional volume of
several FG and inferior temporal gyrus coordinates was positively
related to immediate and delayed relaxation in HCs. Moreover,
none of the temporal coordinates with a negative association
in PwMS did spatially overlap with any of the coordinates
found in HCs—neither with those showing a positive, nor
with those showing a negative association with immediate or
delayed relaxation in HCs. Consequently, given the similarity
with findings obtained in resilience and PTSD studies, the results
of this supplementary analysis argue that the somewhat counter-
intuitive negative association between temporal areas in GM
regions and relaxation in PwMS is a valid finding not driven by
measurement error. Moreover, given the missing spatial overlap
between coordinates found in the more sensitive supplementary
HC analysis and the coordinates with negative associations found
in the more conservative PwMS analysis, one might assume
that the negative associations found in PwMS are driven by a
disease-specific process.
Finally, in supplementary VBM analysis 4, we evaluated
whether the association between regional GM volume variations
and relaxation in PwMS found in the first VBM analysis
presented in the main text was driven by the MS disease
progression by repeating the first main analysis with an
additional covariate of no interest that reflected whether a given
patient was a relapsing-remitting or a secondary progressive MS
patient. Given the very strong overlap between results obtained in
the main and the supplementary VBM analysis, one can conclude
that the impact of a progressive disease type on the association
between perceived relaxation and regional GM volume in PwMS
is negligible.
A limitation of the study is the fact that although there
are findings in the literature allowing to speculate on how
regional GM variations might lead to a different link between
relaxation and regional volume in VMPFC or temporal areas in
PwMS than HC, the explanations derived from these findings
remain speculative. Consequently, the investigation of more
specific mechanisms underlying these associations incorporating
additional MS-related neurobiological parameters such as T-cell
glucocorticoid (in-) sensitivity [cf. (6, 44)] remains a target of
future studies.
Taken together, we found a differential coupling between
relaxation and regional VMPFC volume in PwMS and HCs as
well as a differential coupling of relaxation and stress-related
heart rate accelerations in PwMS and HCs that appear to reflect a
systematic misinterpretation of stress signals in MS.
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